• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估单中心和多中心肿瘤成像试验中PET/CT测量偏差的交叉校准锗/镓体模的评估

Evaluation of Cross-Calibrated Ge/Ga Phantoms for Assessing PET/CT Measurement Bias in Oncology Imaging for Single- and Multicenter Trials.

作者信息

Byrd Darrin W, Doot Robert K, Allberg Keith C, MacDonald Lawrence R, McDougald Wendy A, Elston Brian F, Linden Hannah M, Kinahan Paul E

机构信息

Department of Radiology, University of Washington, Seattle, Washington.

Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania.

出版信息

Tomography. 2016 Dec;2(4):353-360. doi: 10.18383/j.tom.2016.00205.

DOI:10.18383/j.tom.2016.00205
PMID:28066807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5214172/
Abstract

Quantitative PET imaging is an important tool for clinical trials evaluating the response of cancers to investigational therapies. The standardized uptake value, used as a quantitative imaging biomarker, is dependent on multiple parameters that may contribute bias and variability. The use of long-lived, sealed PET calibration phantoms offers the advantages of known radioactivity activity concentration and simpler use than aqueous phantoms. We evaluated scanner and dose calibrator sources from two batches of commercially available kits, together at a single site and distributed across a local multicenter PET imaging network. We found that radioactivity concentration was uniform within the phantoms. Within the regions of interest drawn in the phantom images, coefficients of variation of voxel values were less than 2%. Across phantoms, coefficients of variation for mean signal were close to 1%. Biases of the standardized uptake value estimated with the kits varied by site and were seen to change in time by approximately ±5%. We conclude that these biases cannot be assumed constant over time. The kits provide a robust method to monitor PET scanner and dose calibrator biases, and resulting biases in standardized uptake values.

摘要

定量PET成像是评估癌症对研究性疗法反应的临床试验的重要工具。用作定量成像生物标志物的标准化摄取值取决于多个可能导致偏差和变异性的参数。使用长寿命、密封的PET校准体模具有放射性活度浓度已知且比水溶液体模使用更简便的优点。我们在单个站点共同评估了来自两批市售试剂盒的扫描仪和剂量校准源,并将其分布在当地的多中心PET成像网络中。我们发现体模内的放射性浓度是均匀的。在体模图像中绘制的感兴趣区域内,体素值的变异系数小于2%。在不同体模中,平均信号的变异系数接近1%。用试剂盒估计的标准化摄取值的偏差因站点而异,并且随时间变化约±5%。我们得出结论,不能假定这些偏差随时间恒定。这些试剂盒提供了一种可靠的方法来监测PET扫描仪和剂量校准器的偏差以及标准化摄取值中产生的偏差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/6037938/68e3833704c0/tom0041600650008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/6037938/fbc600a6dada/tom0041600650001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/6037938/3c9f81db7292/tom0041600650002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/6037938/43a56f3e7aad/tom0041600650003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/6037938/76894b2fd21b/tom0041600650004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/6037938/12cedefdeb8c/tom0041600650005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/6037938/731f0af9882b/tom0041600650006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/6037938/0511880c8215/tom0041600650007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/6037938/68e3833704c0/tom0041600650008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/6037938/fbc600a6dada/tom0041600650001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/6037938/3c9f81db7292/tom0041600650002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/6037938/43a56f3e7aad/tom0041600650003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/6037938/76894b2fd21b/tom0041600650004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/6037938/12cedefdeb8c/tom0041600650005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/6037938/731f0af9882b/tom0041600650006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/6037938/0511880c8215/tom0041600650007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f46/6037938/68e3833704c0/tom0041600650008.jpg

相似文献

1
Evaluation of Cross-Calibrated Ge/Ga Phantoms for Assessing PET/CT Measurement Bias in Oncology Imaging for Single- and Multicenter Trials.用于评估单中心和多中心肿瘤成像试验中PET/CT测量偏差的交叉校准锗/镓体模的评估
Tomography. 2016 Dec;2(4):353-360. doi: 10.18383/j.tom.2016.00205.
2
Quantitative PET/CT scanner performance characterization based upon the society of nuclear medicine and molecular imaging clinical trials network oncology clinical simulator phantom.基于核医学与分子影像学会临床试验网络肿瘤学临床模拟体模的定量 PET/CT 扫描仪性能特征描述。
J Nucl Med. 2015 Jan;56(1):145-52. doi: 10.2967/jnumed.114.148056. Epub 2014 Dec 18.
3
Measuring temporal stability of positron emission tomography standardized uptake value bias using long-lived sources in a multicenter network.在多中心网络中使用长寿命源测量正电子发射断层扫描标准化摄取值偏差的时间稳定性。
J Med Imaging (Bellingham). 2018 Jan;5(1):011016. doi: 10.1117/1.JMI.5.1.011016. Epub 2018 Jan 4.
4
Biases in Multicenter Longitudinal PET Standardized Uptake Value Measurements.多中心纵向 PET 标准化摄取值测量中的偏倚。
Transl Oncol. 2014 Feb 1;7(1):48-54. doi: 10.1593/tlo.13850. eCollection 2014 Feb.
5
Calibration Software for Quantitative PET/CT Imaging Using Pocket Phantoms.使用袖珍体模的定量PET/CT成像校准软件
Tomography. 2018 Sep;4(3):148-158. doi: 10.18383/j.tom.2018.00020.
6
Multicenter study of quantitative PET system harmonization using NIST-traceable Ge/Ga cross-calibration kit.使用 NIST 可溯源的 Ge/Ga 交叉校准套件进行定量 PET 系统的多中心研究
Phys Med. 2018 Aug;52:98-103. doi: 10.1016/j.ejmp.2018.07.001. Epub 2018 Jul 7.
7
Simultaneous Estimation of Bias and Resolution in PET Images With a Long-Lived "Pocket" Phantom System.使用长寿命“口袋”体模系统同时估计PET图像中的偏差和分辨率
Tomography. 2018 Mar;4(1):33-41. doi: 10.18383/j.tom.2018.00004.
8
The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma).意大利淋巴瘤基金会(FIL)采用的基于(68)锗体模的 FDG-PET 临床试验站点资格认证计划。
Phys Med. 2016 May;32(5):651-6. doi: 10.1016/j.ejmp.2016.04.004. Epub 2016 Apr 28.
9
Underestimation of Ga PET/CT SUV caused by activity overestimation using default calibrator settings.使用默认校准器设置导致 Ga PET/CT SUV 低估。
Phys Med. 2019 Mar;59:158-162. doi: 10.1016/j.ejmp.2019.03.006. Epub 2019 Mar 11.
10
A phantom-based method to standardize dose-calibrators for new β+-emitters.一种基于模体的方法,用于对新型β⁺发射体的剂量校准器进行标准化。
Nucl Med Commun. 2015 Feb;36(2):201-6. doi: 10.1097/MNM.0000000000000227.

引用本文的文献

1
[18 F]-Fluoroestradiol PET (FES-PET) and [18 F] Flurodeoxyglucose PET (FDG-PET) Imaging May Aid in Managing Therapy in Patients with Metastatic Lobular Breast Cancer.[18F]氟雌二醇正电子发射断层扫描(FES-PET)和[18F]氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)成像可能有助于转移性小叶乳腺癌患者的治疗管理。
Mol Imaging Biol. 2025 May 14. doi: 10.1007/s11307-025-02015-2.
2
Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancer.氟雌二醇(FES)和氟脱氧葡萄糖(FDG)正电子发射断层显像(PET)在雌激素受体阳性、人表皮生长因子受体2阳性或人表皮生长因子受体2阴性转移性乳腺癌患者中的应用。
Breast Cancer Res. 2025 Feb 17;27(1):23. doi: 10.1186/s13058-025-01975-1.
3

本文引用的文献

1
The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma).意大利淋巴瘤基金会(FIL)采用的基于(68)锗体模的 FDG-PET 临床试验站点资格认证计划。
Phys Med. 2016 May;32(5):651-6. doi: 10.1016/j.ejmp.2016.04.004. Epub 2016 Apr 28.
2
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.美国采用早期中期氟脱氧葡萄糖-正电子发射断层扫描成像对Ⅲ至Ⅳ期霍奇金淋巴瘤进行适应性治疗的多中心试验:西南肿瘤协作组S0816。
J Clin Oncol. 2016 Jun 10;34(17):2020-7. doi: 10.1200/JCO.2015.63.1119. Epub 2016 Apr 11.
3
Repeatability of F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials.
乳腺癌患者转移性骨病变中F-FDG摄取的重复性及其对临床试验入组的影响。
EJNMMI Res. 2024 Mar 27;14(1):32. doi: 10.1186/s13550-024-01093-7.
4
Animal Models and Their Role in Imaging-Assisted Co-Clinical Trials.动物模型及其在影像辅助的临床试验中的作用。
Tomography. 2023 Mar 16;9(2):657-680. doi: 10.3390/tomography9020053.
5
Current status and future of targeted peptide receptor radionuclide positron emission tomography imaging and therapy of gastroenteropancreatic-neuroendocrine tumors.胃肠胰神经内分泌肿瘤靶向肽受体放射性核素正电子发射断层成像与治疗的现状与未来。
World J Gastroenterol. 2022 May 7;28(17):1768-1780. doi: 10.3748/wjg.v28.i17.1768.
6
Evaluation of primary breast cancers using dedicated breast PET and whole-body PET.使用专用乳腺 PET 和全身 PET 对原发性乳腺癌进行评估。
Sci Rep. 2020 Dec 14;10(1):21930. doi: 10.1038/s41598-020-78865-3.
7
F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2- Metastatic Breast Cancer.氟维司群 PET 显像在唑来膦酸治疗 ER+/HER2-转移性乳腺癌以恢复内分泌敏感性的 II 期试验中。
J Nucl Med. 2021 Feb;62(2):184-190. doi: 10.2967/jnumed.120.244459. Epub 2020 Jun 26.
8
Bias in PET Images of Solid Phantoms Due to CT-Based Attenuation Correction.基于CT的衰减校正导致实体模型PET图像中的偏差。
Tomography. 2019 Mar;5(1):154-160. doi: 10.18383/j.tom.2018.00043.
9
Test-Retest Reproducibility of F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network.在合格和校准的本地网络内,癌症患者 F-FDG PET/CT 摄取的测试-重测可重复性。
J Nucl Med. 2019 May;60(5):608-614. doi: 10.2967/jnumed.118.209544. Epub 2018 Oct 25.
10
Performance assessment of diffuse optical spectroscopic imaging instruments in a 2-year multicenter breast cancer trial.在一项为期 2 年的多中心乳腺癌试验中评估漫射光学光谱成像仪器的性能。
J Biomed Opt. 2017 Dec 1;22(12):121604. doi: 10.1117/1.JBO.22.12.121604. Epub 2017 Aug 17.
Impact of Recent Change in the National Institute of Standards and Technology Standard for 18F on the Relative Response of 68Ge-Based Mock Syringe Dose Calibrator Standards.
美国国家标准与技术研究院18F标准近期变化对基于68Ge的模拟注射器剂量校准器标准相对响应的影响
J Nucl Med. 2015 Sep;56(9):1453-7. doi: 10.2967/jnumed.115.159384. Epub 2015 Jul 16.
4
How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.在靶向癌症治疗时代,影像生物标志物如何为临床试验和临床实践提供信息。
JAMA Oncol. 2015 Jul;1(4):421-2. doi: 10.1001/jamaoncol.2015.0667.
5
How Imaging Can Impact Clinical Trial Design: Molecular Imaging as a Biomarker for Targeted Cancer Therapy.成像如何影响临床试验设计:分子成像作为靶向癌症治疗的生物标志物
Cancer J. 2015 May-Jun;21(3):218-24. doi: 10.1097/PPO.0000000000000116.
6
Performance assessment of a NaI(Tl) gamma counter for PET applications with methods for improved quantitative accuracy and greater standardization.使用提高定量准确性和更大标准化的方法对用于正电子发射断层扫描(PET)应用的碘化钠(铊)γ 计数器进行性能评估。
EJNMMI Phys. 2015 May;2. doi: 10.1186/s40658-015-0114-3.
7
Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials.肿瘤临床试验中18F-FDG PET/CT成像的UPICT方案总结。
J Nucl Med. 2015 Jun;56(6):955-61. doi: 10.2967/jnumed.115.158402. Epub 2015 Apr 16.
8
Developing biomarker-specific end points in lung cancer clinical trials.在肺癌临床试验中开发针对生物标志物的终点。
Nat Rev Clin Oncol. 2015 Mar;12(3):135-46. doi: 10.1038/nrclinonc.2014.222. Epub 2014 Dec 23.
9
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描:欧洲核医学与分子影像学会肿瘤显像程序指南:第2.0版。
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54. doi: 10.1007/s00259-014-2961-x. Epub 2014 Dec 2.
10
Biases in Multicenter Longitudinal PET Standardized Uptake Value Measurements.多中心纵向 PET 标准化摄取值测量中的偏倚。
Transl Oncol. 2014 Feb 1;7(1):48-54. doi: 10.1593/tlo.13850. eCollection 2014 Feb.